High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia
- Conditions
- Fibromyalgia
- Registration Number
- NCT05904990
- Lead Sponsor
- October 6 University
- Brief Summary
This study will be conducted to investigate High-intensity laser therapy improves pain, health status and quality of life in women with fibromyalgia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 52
- WPI ≥ 7/19 pain sites and SSS ≥ 5/12 or WPI between > 3-6/19 and SSS > 9/12
- symptoms have been present at a similar level for at least 3 months
- the patient does not have another disorder that would otherwise sufficiently explain the pain
- generalized pain, defined as pain in at least four of five regions, is present
- uncontrolled diabetes
- known history of cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Visual Analog Scale (VAS) up to 6 weeks 10 cm, where patients rated their pain on a scale from 0 ("no pain") to 10 ("extremely severe pain ") over the past 3 days
Revised Fibromyalgia Impact Questionnaire (FIQR) up to 6 weeks assesses the overall severity of FM and health status based on participant ratings. It encompasses three key domains similar to the FIQ (function, overall impact, and symptoms), with additional inquiries regarding memory, tenderness, balance, and environmental sensitivity
pressure algometer up to 6 weeks This tool comprises a circular rubber tip (1 cm2) and a pressure gauge for displaying readings in kilograms. Given the rubber tip's 1 cm² area, measurements were reported in kilograms per square centimeter (kg/cm2). The algometer has a measurement range from 0 to 10 kg, with increments of 0.1 kg. The instrument was pressed against the skin's surface at a right angle, and the force exerted was registered on a manometer.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Kerolous Ishak Shehata Kelini
🇪🇬Giza, Egypt
Kerolous Ishak Shehata Kelini🇪🇬Giza, Egypt